What are the moral rights an original screenwriter retains after selling a spec script to a studio in 2027?

The outcome you should expect

The practical outcome for a screenwriter selling an original spec script in 2027 is a split-rights reality. The studio acquires the copyright in the literary work — the script itself — and with it the exclusive rights to reproduce, adapt, distribute, publicly perform, and create derivative works such as the produced film. What the screenwriter retains depends almost entirely on the jurisdiction whose law governs the contract and the work.

In the United States, the Copyright Act does not recognize a broad moral rights doctrine. Instead, the Visual Artists Rights Act of 1990 grants attribution and integrity rights only to a narrow category of works — paintings, drawings, prints, sculptures, and certain photographic images produced for exhibition — and explicitly excludes audiovisual works and, by extension, the screenplay as a literary work. So a U.S.-based screenwriter who sells a spec script to a Hollywood studio usually retains no statutory moral rights in the script or the resulting film. What they retain instead is whatever the contract grants them: screenplay credit, separated rights under the Writers Guild of America Minimum Basic Agreement, and any negotiated approvals or reversion rights.

Outside the United States, the picture changes dramatically. Most countries that signed the Berne Convention — which includes nearly every major film market except the U.S. in practice — recognize moral rights as inalienable. In France, for example, the droit moral includes the right of paternity (attribution), the right of integrity (protection against mutilation or distortion), the right of disclosure (deciding when the work is made public), and the right of withdrawal (pulling the work back in certain circumstances). These rights cannot be sold or waived outright; a screenwriter can agree not to exercise them, but the underlying rights remain attached to the author.

The outcome, then, is that a screenwriter selling an original spec script in 2027 should expect to lose economic control but to retain a variable bundle of moral rights depending on where they live, where the studio operates, and what the contract says. The safe assumption is that moral rights are not automatically gone — but they are also not automatically enforceable. The contract and the governing law are the two levers that determine everything.

A second outcome to expect is that moral rights are increasingly treated as a negotiating chip rather than a fixed legal baseline. Studios in 2027 often ask for broad waivers of moral rights as a condition of purchase, especially for international co-productions that need to clear rights in multiple jurisdictions. A screenwriter who wants to preserve attribution or integrity protections must negotiate them explicitly, because the default in a U.S.-governed contract is that they are waived or never existed.

Finally, expect the outcome to vary by medium. The moral rights a screenwriter retains in the script as a literary work may differ from the moral rights they retain in the film as an audiovisual work. In many jurisdictions, the director is treated as the primary author of the audiovisual work, which can push the screenwriter's moral rights into a secondary position. The screenwriter's strongest moral claim is usually to the script itself, not to the final cut.

What drives that outcome

Several forces determine which moral rights a screenwriter retains after selling an original spec script. The first and most important is the governing law clause in the purchase agreement. If the contract specifies California law or New York law, U.S. moral rights doctrine applies, which means the screenwriter retains almost nothing statutory. If the contract specifies French, German, or Canadian law, the screenwriter retains a much stronger bundle of inalienable rights.

The second driver is the Berne Convention and its implementation in each country. Berne Article 6bis requires member states to recognize moral rights of attribution and integrity, independent of economic rights, and to keep them in force at least until the expiration of copyright. The United States ratified Berne in 1989 but took the position that its existing law — including VARA and the Lanham Act — satisfied the obligation, which is why U.S. moral rights remain narrow. A screenwriter selling into a Berne country can often rely on 6bis even if the contract is silent.

The third driver is the Writers Guild of America Minimum Basic Agreement. The MBA does not create moral rights in the copyright sense, but it does create contractual credit rights. Under the MBA, a screenwriter who writes an original screenplay is entitled to sole "Screenplay by" credit if they are the sole writer, and the credit must appear in a specified size and placement. The MBA also gives the original screenwriter separated rights — the right to exploit the script in other media, such as stage and radio, under certain conditions. These are contractual, not moral, but they function like moral rights in practice.

The fourth driver is the distinction between the script and the film. A screenwriter's moral rights in the script as a literary work are separate from any moral rights in the film as an audiovisual work. In jurisdictions that recognize the director as the author of the audiovisual work, the screenwriter's moral rights may be limited to the script and may not extend to the final film. This is why a screenwriter can sometimes object to a changed line in the shooting script but not to a re-cut of the finished film.

The fifth driver is the contract's waiver and assignment language. Even in jurisdictions where moral rights are inalienable, a screenwriter can agree not to exercise them. A typical studio purchase agreement in 2027 includes a clause in which the screenwriter waives all moral rights "to the fullest extent permitted by law." In France, such a waiver may be unenforceable as to the underlying right, but it can still create a contractual estoppel that makes it difficult for the screenwriter to sue. In the U.S., the waiver is largely redundant because the rights do not exist for screenplays, but it is included for belt-and-suspenders reasons.

The sixth driver is the rise of streaming and international co-production. A studio that distributes a film in 190 countries needs to clear moral rights in all of them. That creates pressure to obtain a global waiver, which in turn pushes screenwriters to negotiate carve-outs for attribution and integrity. The result is a patchwork: a screenwriter may retain strong moral rights in France, weak ones in the U.S., and contractual credit rights everywhere the WGA agreement applies.

A useful way to think about the driver stack is to separate the rights that come from law from the rights that come from contract. Law-based moral rights — paternity, integrity, disclosure, withdrawal — are strongest in civil-law countries and weakest in the United States. Contract-based rights — credit, separated rights, approvals, reversion — are strongest where the WGA MBA applies and where the screenwriter has leverage. A screenwriter selling an original spec script in 2027 should map both stacks before signing, because the contract can either reinforce or undermine the statutory baseline.

Benchmarks and realistic ranges

Realistic benchmarks for moral rights retention in 2027 vary widely by jurisdiction and by the screenwriter's leverage. In the United States, the benchmark is that a screenwriter retains no statutory moral rights in the script or film, but does retain contractual credit rights under the WGA MBA. The WGA minimum for an original screenplay in 2027 is in the low six figures for a high-budget studio film, and the credit provisions are non-negotiable for signatory studios. That means a U.S. screenwriter can expect a guaranteed "Screenplay by" credit and arbitration if credit is disputed, but no legal right to object to changes in the script or the film.

In France, the benchmark is the opposite. A screenwriter retains the droit moral in full, including paternity, integrity, disclosure, and withdrawal. The right of integrity allows the screenwriter to object to modifications that distort the spirit of the work, and French courts have enforced this even against producers. The right of withdrawal is rarely exercised but exists. A French screenwriter selling an original spec script to a French studio can expect to retain these rights unless the contract includes a specific and limited waiver, which French courts scrutinize closely.

In Germany, the benchmark is similar to France but with a stronger emphasis on the author's right to determine the fate of the work. The Urheberrechtsgesetz grants the author moral rights that are inalienable, and a screenwriter retains the right to be named and the right to protect the work's integrity. German law also recognizes the right to access the work, which can matter for a screenwriter who wants to see how the script was used.

In the United Kingdom, the benchmark is a middle ground. The Copyright, Designs and Patents Act 1988 grants moral rights of paternity and integrity, but these can be waived by written agreement. A screenwriter selling an original spec script to a UK studio can expect to retain moral rights unless the contract includes a waiver, which is common. The right of integrity in the UK is narrower than in France; it applies to derogatory treatment, not to any modification.

In Canada, the benchmark is closer to the UK. The Copyright Act grants moral rights of attribution and integrity that cannot be assigned but can be waived. A Canadian screenwriter selling to a Canadian studio can expect to retain moral rights unless they waive them. The waiver must be in writing and can be limited to specific acts.

Realistic ranges for negotiation in 2027 are as follows. A U.S. screenwriter with leverage can negotiate a credit provision that goes beyond the WGA minimum, such as a guaranteed "Written by" credit and a "Story by" credit for the original idea. A screenwriter selling into a Berne country can negotiate a limited waiver that preserves attribution and integrity while allowing the studio to make reasonable changes. A screenwriter in a co-production can negotiate a choice-of-law clause that selects a jurisdiction with strong moral rights, which can preserve the bundle even if the studio is U.S.-based.

The benchmark for enforcement is also worth noting. In the U.S., a screenwriter who wants to enforce credit must go through WGA arbitration, which is binding and relatively fast. In France, a screenwriter can sue in court for moral rights violations, and damages can include injunctive relief. In Germany, the author can seek injunctive relief and damages. In the UK and Canada, moral rights claims are possible but less common, and the remedies are often limited to damages.

A final benchmark is the treatment of moral rights in the streaming era. A screenwriter selling an original spec script to a streamer in 2027 should expect the same moral rights analysis as a studio sale, but with two differences. First, streamers often insist on global waivers because they distribute worldwide. Second, streamers may not be signatories to the WGA MBA, which means credit rights are not guaranteed unless the screenwriter negotiates them. The benchmark for a streamer sale is therefore weaker on both statutory and contractual fronts, and a screenwriter should push for a credit provision and a limited moral rights waiver.

Risks, edge cases, and failure modes

The first risk is that a screenwriter assumes moral rights are automatically retained and fails to negotiate them. In the U.S., that assumption is wrong for screenplays, and a screenwriter who does not negotiate credit or approvals may find that the studio has no obligation to credit them beyond the WGA minimum. In a Berne country, the assumption may be correct, but the contract may include a waiver that the screenwriter did not read carefully. The failure mode is a screenwriter who loses attribution or integrity protection because they did not push back on a boilerplate waiver.

The second risk is the choice-of-law clause. A screenwriter selling an original spec script to a U.S. studio may sign a contract governed by California law, which means U.S. moral rights doctrine applies even if the screenwriter lives in France. The failure mode is a French screenwriter who assumes their droit moral travels with them, only to find that the contract's choice-of-law clause displaces it. The fix is to negotiate a carve-out that preserves the screenwriter's moral rights under their home jurisdiction, or to select a neutral jurisdiction with strong moral rights.

The third risk is the distinction between the script and the film. A screenwriter may retain moral rights in the script but not in the film, which means they can object to changes in the published script but not to changes in the film. The failure mode is a screenwriter who objects to a re-cut of the film and discovers they have no standing because the film is a separate work authored by the director. The fix is to negotiate a contractual right to be consulted on material changes to the script as used in the film, even if that right is not a moral right.

The fourth risk is the waiver of moral rights in a jurisdiction where the waiver is unenforceable. In France, a waiver of moral rights may be void, but the screenwriter may still be bound by a contractual promise not to sue. The failure mode is a screenwriter who believes they have retained their moral rights but is contractually barred from enforcing them. The fix is to have a French lawyer review the waiver and to negotiate a limited waiver that is enforceable and specific.

The fifth risk is the WGA credit arbitration process. A screenwriter who is not a WGA member may not have access to arbitration, and a screenwriter who is a member may still lose credit if the studio argues that the final script is substantially different from the original. The failure mode is a screenwriter who wrote the original spec script but is denied credit because a subsequent writer did a page-one rewrite. The fix is to negotiate a "Story by" credit that survives rewrites, or to include a credit provision in the purchase agreement that is independent of the MBA.

The sixth risk is the international co-production. A film that is a co-production between a U.S. studio and a French studio may be subject to both U.S. and French law, which creates conflicts. The failure mode is a screenwriter who retains moral rights under French law but cannot enforce them because the U.S. co-producer controls the final cut. The fix is to negotiate a choice-of-law clause that selects the jurisdiction with the strongest moral rights, and to include a dispute resolution clause that allows the screenwriter to sue in that jurisdiction.

The seventh risk is the rise of AI-assisted writing. A screenwriter who uses AI tools to generate or revise a spec script may find that the resulting work has uncertain authorship, which can affect moral rights. The failure mode is a screenwriter who cannot claim attribution because the work is deemed to be jointly authored by the AI tool's developer. The fix is to document the human authorship of the script and to negotiate a representation that the screenwriter is the sole author.

A practical rollout plan

A practical plan for a screenwriter selling an original spec script in 2027 starts before the sale. The first step is to identify the jurisdictions that will govern the contract and the work. If the studio is U.S.-based, assume U.S. moral rights doctrine applies unless the contract says otherwise. If the studio is in a Berne country, assume strong moral rights apply unless the contract includes a waiver. The screenwriter should ask for the choice-of-law clause early and have a lawyer in that jurisdiction review it.

The second step is to negotiate the credit provision. In the U.S., the WGA MBA provides a baseline, but a screenwriter with leverage can negotiate a "Written by" credit and a "Story by" credit that survive rewrites. In a Berne country, the screenwriter should confirm that the right of paternity is preserved and that the credit will appear in the specified form. The screenwriter should also negotiate a right to be consulted on material changes to the script, even if that right is contractual rather than moral.

The third step is to negotiate the moral rights waiver. In the U.S., the waiver is largely redundant, but the screenwriter should still limit it to the extent permitted by law. In a Berne country, the screenwriter should resist a blanket waiver and instead negotiate a limited waiver that preserves attribution and integrity while allowing the studio to make reasonable changes. The screenwriter should also negotiate a carve-out that preserves their moral rights under their home jurisdiction if the contract is governed by a foreign law.

The fourth step is to negotiate the separated rights. Under the WGA MBA, the original screenwriter retains separated rights in the script, which allows them to exploit the script in other media such as stage, radio, and television. The screenwriter should confirm that these rights are preserved and should negotiate any additional rights, such as sequel rights or remake rights, that they want to retain.

The fifth step is to negotiate the reversion right. A reversion right allows the screenwriter to regain the rights to the script if the studio does not produce the film within a specified period. The screenwriter should negotiate a reversion clause that is triggered by a defined event, such as the studio's failure to commence production within three years. The reversion right is not a moral right, but it functions like one by giving the screenwriter control over the work's fate.

The sixth step is to document everything. The screenwriter should keep a record of the negotiation, including the choice-of-law clause, the credit provision, the moral rights waiver, the separated rights, and the reversion clause. The screenwriter should also keep a copy of the final script and any drafts, because these may be needed to prove authorship if credit is disputed.

The seventh step is to monitor the production. The screenwriter should review the shooting script and the final cut to ensure that the credit is correct and that the work has not been distorted. If the screenwriter has a consultation right, they should exercise it. If the screenwriter believes their moral rights have been violated, they should consult a lawyer in the relevant jurisdiction and consider whether to sue or to seek arbitration.

The eighth step is to plan for the long term. Moral rights in many jurisdictions last for the life of the author plus 70 years, which means the screenwriter's heirs may inherit them. The screenwriter should include moral rights in their estate plan and should ensure that their heirs know how to enforce them. The screenwriter should also consider whether to register the script with the U.S. Copyright Office or a equivalent body, because registration can help prove authorship and can affect the availability of statutory damages.

A final step is to stay informed. Moral rights law is evolving, especially in the U.S., where courts have occasionally used the Lanham Act and state law to protect authors. The screenwriter should follow developments in the WGA MBA, in Berne Convention implementation, and in the law of the jurisdictions where their work is distributed. The screenwriter should also consider joining a guild or an authors' association that can provide advice and support.

Related questions

Can a screenwriter waive moral rights in the United States?

Yes, but the waiver is largely redundant for screenplays because U.S. law does not grant moral rights to literary works. The waiver matters mainly for works covered by VARA, such as certain visual art. A screenwriter can still negotiate contractual credit rights.

Do moral rights survive the sale of a spec script in France?

Yes. French law treats moral rights as inalienable, so a screenwriter retains paternity, integrity, disclosure, and withdrawal rights even after selling the economic rights. A waiver may be unenforceable, but a contractual promise not to sue can still limit enforcement.

What is the difference between moral rights and copyright?

Copyright covers economic rights such as reproduction, distribution, and adaptation, and it can be sold or licensed. Moral rights cover attribution and integrity, are personal to the author, and are generally inalienable in civil-law countries. In the U.S., moral rights are narrow.

Does the WGA protect moral rights?

The WGA MBA does not create moral rights in the copyright sense, but it does create contractual credit rights and separated rights. These function like moral rights by guaranteeing attribution and giving the screenwriter some control over the work's use in other media.

How long do moral rights last?

In most Berne Convention countries, moral rights last for the life of the author plus 70 years, and they pass to the author's heirs. In the U.S., VARA rights last for the life of the author, and for works of joint authorship, for the life of the last surviving author.

FAQ

What are the moral rights an original screenwriter retains after selling a spec script to a studio in 2027?

The answer depends on the governing law. In the U.S., a screenwriter retains no statutory moral rights in the script or film, but retains contractual credit rights under the WGA MBA. In France, Germany, and other Berne countries, the screenwriter retains inalienable moral rights of paternity, integrity, disclosure, and withdrawal. The contract's choice-of-law clause and waiver language determine which bundle applies.

Can a studio force a screenwriter to waive moral rights?

In the U.S., a studio can ask for a waiver, but it is largely redundant for screenplays. In civil-law countries, a blanket waiver may be unenforceable, but a contractual promise not to sue can still limit enforcement. A screenwriter should negotiate a limited waiver that preserves attribution and integrity.

What is the right of integrity in the context of a screenplay?

The right of integrity allows the screenwriter to object to modifications that distort or mutilate the work. In France, this right is strong and can be enforced against producers. In the U.S., it does not apply to screenplays. In the UK and Canada, it applies to derogatory treatment but can be waived.

Does the screenwriter retain moral rights in the film or only in the script?

In many jurisdictions, the director is treated as the author of the audiovisual work, so the screenwriter's moral rights may be limited to the script. The screenwriter's strongest moral claim is usually to the script as a literary work, not to the final film. A contractual consultation right can bridge the gap.

How can a screenwriter enforce moral rights after selling a script?

Enforcement depends on the jurisdiction. In France and Germany, the screenwriter can sue for injunctive relief and damages. In the U.S., the screenwriter must rely on WGA arbitration for credit and on contract law for other claims. In the UK and Canada, moral rights claims are possible but less common.

What happens to moral rights if the studio never produces the film?

If the studio never produces the film, the screenwriter's moral rights in the script remain intact. The screenwriter may also have a reversion right that allows them to regain the economic rights if production does not commence within a specified period. The reversion right is contractual, not moral, but it gives the screenwriter control over the work's fate.

Sources

• https://www.wga.org/contracts/contracts/mba
• https://www.copyright.gov/title17/92chap1.html
• https://www.wipo.int/wipolex/en/text/283698
• https://www.legifrance.gouv.fr/codes/article_lc/LEGIARTI000006278917
• https://www.gesetze-im-internet.de/urhg/BJNR012730965.html
• https://www.legislation.gov.uk/ukpga/1988/48/contents
• https://laws-lois.justice.gc.ca/eng/acts/C-42/
• https://www.berneconvention.org/
• https://www.copyright.gov/circs/circ40.pdf

Related on PULSE

• What is the Writers Guild of America Minimum Basic Agreement?
• How do separated rights work for screenwriters?
• What is the difference between a spec script and a commissioned script?
• How does copyright law treat screenplays in the United States?
• What is the droit moral in French copyright law?
• How do international co-productions handle rights clearance?